Events

E2i Symposium 3 - Strengthening strategic and operational impact in European Security R&I
SEP
Wed
23
10:00 - 17:00

Starts in 1 month from now

Location

Brussels

Programmes
Civil Security

Making Innovation Count is the third annual symposium of the Horizon Europe-funded Engage2innovate (E2i) project. This one-day event will bring together security researchers, practitioners, policymakers and innovators from across Europe to address some of the most challenging and consequential questions facing European security R&I

  • Are we funding impactful security innovation — or just producing reports?
  • What would make security innovation genuinely usable for real end-users in real operational contexts?
  • How can insights from past R&I project investments better inform the security innovation agenda of tomorrow?
  • What would it take to build a genuinely learning European Security R&I ecosystem? One that properly benefits from the knowledge good R&I generates — rather than simply shelving it?

For more information and to register, please visit the event page: E2i Symposium 3

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.